Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
Islam K, Hossain M, Kelly M, Mayo Smith LM, Charles RC, Bhuiyan TR, Kováč P, Xu P, LaRocque RC, Calderwood SB, Simon JK, Chen WH, Haney D, Lock M, Lyon CE, Kirkpatrick BD, Cohen M, Levine MM, Gurwith M, Harris JB, Qadri F, Ryan ET.
PLoS Negl Trop Dis. 2018 Apr 6;12(4):e0006376. doi: 10.1371/journal.pntd.0006376. eCollection 2018 Apr.
The phospholipase effector Tle1(Vc) promotes Vibrio cholerae virulence by killing competitors and impacting gene expression.
Liu M, Wang H, Liu Y, Tian M, Wang Z, Shu RD, Zhao MY, Chen WD, Wang H, Wang H, Fu Y.
Gut Microbes. 2023 Jan-Dec;15(1):2241204. doi: 10.1080/19490976.2023.2241204.
Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study.
El-Haggar SM, Hegazy SK, Maher MM, Bahgat MM, Bahaa MM.
Int Immunopharmacol. 2024 Sep 10;138:112541. doi: 10.1016/j.intimp.2024.112541. Epub 2024 Jun 24.
Spheroplast-Mediated Carbapenem Tolerance in Gram-Negative Pathogens.
Cross T, Ransegnola B, Shin JH, Weaver A, Fauntleroy K, VanNieuwenhze MS, Westblade LF, Dörr T.
Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00756-19. doi: 10.1128/AAC.00756-19. Print 2019 Sep.
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.
O'Ryan M, Vidal R, del Canto F, Carlos Salazar J, Montero D.
Hum Vaccin Immunother. 2015;11(3):601-19. doi: 10.1080/21645515.2015.1011578.
Whole-genome-based characterization of Escherichia albertii strains isolated from paediatric diarrhoeal cases in Kolkata, India.
Chowdhury G, Hoshiko Y, Okuno M, Kitahara K, Albert MJ, Miyoshi SI, Ogura Y, Dutta S, Ramamurthy T, Mukhopadhyay AK.
Microb Genom. 2025 Apr;11(4):001363. doi: 10.1099/mgen.0.001363.
Increased incidence of vibriosis in Maryland, U.S.A., 2006-2019.
Morgado ME, Brumfield KD, Mitchell C, Boyle MM, Colwell RR, Sapkota AR.
Environ Res. 2024 Mar 1;244:117940. doi: 10.1016/j.envres.2023.117940. Epub 2023 Dec 14.
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
Kamruzzaman M, Kelly M, Charles RC, Harris JB, Calderwood SB, Akter A, Biswas R, Kaisar MH, Bhuiyan TR, Ivers LC, Ternier R, Jerome JG, Pfister HB, Lu X, Soliman SE, Ruttens B, Saksena R, Mečárová J, Čížová A, Qadri F, Bystrický S, Kováč P, Xu P, Ryan ET.
mSphere. 2021 Aug 25;6(4):e0011421. doi: 10.1128/mSphere.00114-21. Epub 2021 Jul 7.
Genomic characterization of the non-O1/non-O139 Vibrio cholerae strain that caused a gastroenteritis outbreak in Santiago, Chile, 2018.
Arteaga M, Velasco J, Rodriguez S, Vidal M, Arellano C, Silva F, Carreño LJ, Vidal R, Montero DA.
Microb Genom. 2020 Mar;6(3):e000340. doi: 10.1099/mgen.0.000340.
A common source foodborne outbreak of cholera in Singapore.
Goh KT, Lam S, Kumarapathy S, Tan JL.
Int J Epidemiol. 1984 Jun;13(2):210-5. doi: 10.1093/ije/13.2.210.
